Selective medicated (saline + natural surfactant) bronchoalveolar lavage in unilateral lung contusion. A clinical randomized controlled trial
- 157 Downloads
Open lung and low tidal volume ventilation appear to be a promising ventilation for chest trauma as it can reduce ARDS and improve outcome. Local therapy (e.g. BAL) can be synergic to remove from the lung the debris, mitigate inflammatory cascade and avoid damage spreading to not compromised lung areas.
Materials and methods
44 pulmonary contused patients were randomized to receive broncho-suction and volume controlled low tidal volume ventilation—VCLTVV (Control Group) or the same ventilation plus medicated (saline + surfactant) BAL (Treatment Group). Tidal volume <10 ml/kg, PEEP of 10-12 cm H2O and PaO2 60–100 mm Hg and PaCO2 35–45 mm Hg were used in both groups. BAL was performed using a fiberscope. 4 boluses of 25 ml saline with 2.4 mg/ml of surfactant were introduced into each contused lobe in which, subsequently, 240 mg of surfactant was instilled.
All patients survived. In the Control Group 18 patients developed pneumonia, 5 ARDS and days of intubation were 11.50 (3.83) compared to 5.05 (1.21) of Treatment Group in which OI and PaO2/FiO2 significantly improved from 36 h.
VCLTVV alone was not able to prevent ARDS and infection in the Control Group as the reduction of intubation. In the Treatment Group, VCLTVV and medicated BAL facilitated the removal of degradated lung material and recruited the contused lung regions, enabling the healing of the lung pathology.
Keywordslung contusion BAL ventilation ARDS surfactant
Unable to display preview. Download preview PDF.
- 10.Wu J, Sheng L, Wang S, et al. Analysis of clinical risk factors associated with the prognosis of severe multiple-trauma patients with acute lung injury. J Emerg Med. 2009. doi: 10.1016/j.jemermed.2009.05.024.
- 20.Seeger W, Elssner A, Gunter A, et al. Lung surfactant phospholipids associate with polymerizing fibrin: loss of surfactant activity. Am J Resp Cell Mol Biol. 1993;9:213–20.Google Scholar
- 24.Strohmaier W, Schalg C. Lung lavage with diluted surfactant is as effective as bolus treatment in a long-term aspiration model. Appl Cardiopul Pathophysiol. 1998;7:17–22.Google Scholar
- 27.Marraro G, Pesci A, Croce AM, et al. Bronchoalveolar lavage (BAL) with porcine derived surfactant in ARDS: hemodynamic and gas exchange assessment. Appl Cardiopul Pathophysiol. 2004;13(suppl):60–1.Google Scholar
- 42.Wright JR, Clements JA. Metabolism and turnover of lung surfactant. Am Rev Respir Dis. 1987;135:426–44.Google Scholar
- 43.Vezzol D, Marraro G, Luchetti M, et al. Bronchopulmonary lavage with Curosurf in ARDS. Biol Neonate. 2002;81(Suppl 1):99–140.Google Scholar
- 46.Gommers D, Eijking EP, So KL, et al. Bronchoalveolar lavage with a diluted surfactant suspension prior to surfactant instillation improves the effectiveness of surfactant therapy in experimental acute respiratory distress syndrome (ARDS). Intensive Care Med. 1998;24:494–500.CrossRefPubMedGoogle Scholar
- 47.Winswell TE, Smith RM, Katz LB, et al. Bronchopulmonary segmental lavage with surfaxin (KL(4)- surfactant) for acute respiratory distress syndrome. Am J Respir Crit Care Med. 1999;160:1188–95.Google Scholar
- 48.Vezzoli D, Marraro GA, Luchetti M, et al. Bronchopulmonary lavage with porcine-derived surfactant in acute lung injury. Acta Pharmacol Sin. 2002;23:117Google Scholar
- 49.Vezzol D, Marraro G, Luchetti M, et al. Bronchopulmonary lavage with Curosurf in acute respiratory di stress sindrome. Biol Neonate. 2002;81(Suppl 1):39Google Scholar
- 51.Chuang-Stein C, Offen W. Analysis of clinical trials using SAS: a practical guide. Cary: SAS Institute Inc; 2005.Google Scholar
- 52.The NPAR1WAY Procedure. SAS/STAT(R) 9.2 User’s Guide. 2nd ed. SAS; 2009. http://support.sas.com/documentation/cdl/en/statug/63033/HTML/default/npar1way_toc.htm. Accessed Oct 2009.